The Efficacy of Abraxane on Osteosarcoma Xenografts in Nude Mice and Expression of Secreted Protein, Acidic and Rich in Cysteine
Authors:
- Xiaohui NiuXNXiaohui Niu
- Qing ZhangQZQing Zhang
- Lin HaoLHLin Hao
- Yi DingYDYi Ding
- Hairong XuHXHairong Xu
- 1 September 2012
- journal article
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 344 (3) , 199-205
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology GroupJournal of Clinical Oncology, 2008
- Multiple Drug Resistance in Osteogenic Sarcoma: INT0133 From the Children's Oncology GroupJournal of Clinical Oncology, 2007
- Improvement in Histologic Response But Not Survival in Osteosarcoma Patients Treated With Intensified Chemotherapy: A Randomized Phase III Trial of the European Osteosarcoma IntergroupJNCI: Journal of the National Cancer Institute, 2007
- Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cellsAnnals of Oncology, 2004
- Phase II study of paclitaxel in patients with previously treated osteosarcoma and its variantsCancer, 1996
- Osteosarcoma: relationship of response to preoperative chemotherapy and type of surgery to local recurrence.Journal of Clinical Oncology, 1996
- High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcomaCancer, 1974
- Recent advances in the chemotherapy of metastatic osteogenic sarcomaCancer, 1972
- Doxorubicin in disseminated osteosarcoma1972
- Osteogenic SarcomaJournal of Bone and Joint Surgery, 1967